Selectis Health (GBCS) Cost of Revenue (2015 - 2026)

Selectis Health has reported Cost of Revenue for 11 years, with the latest figure at $7.0 million in Q4 2025.

• Quarterly Cost of Revenue fell 10.99% year-over-year to $7.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.8 million (up 4.61% YoY) and the FY2025 annual result came in at $31.8 million, up 4.61% from the prior year.
• Cost of Revenue slipped to $7.0 million in Q4 2025 per GBCS's latest filing, from $8.5 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $8.9 million in Q4 2021 and troughed at $3.5 million in Q1 2021.
• A 5-year average of $7.2 million and a median of $7.5 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue surged 96.4% in 2022, then declined 11.85% in 2024.
• Over 5 years, Cost of Revenue stood at $8.9 million in 2021, then fell by 2.18% to $8.7 million in 2022, then slipped by 10.66% to $7.7 million in 2023, then advanced by 1.61% to $7.9 million in 2024, then fell by 10.99% to $7.0 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $7.0 million, $8.5 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.